All In Biotech

Free tool

FAERS Monitor: Xenazine

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021894 or its brand name (Xenazine, Tetrabenazine). Reports on generic versions are filed under their own applications.

Reports

7,327

Serious

4,082

56% of reports

Hospitalization

1,509

Death reported

1,533

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death1,222
  • off label use1,138
  • drug ineffective708
  • depression476
  • somnolence451
  • fatigue361
  • fall318
  • hospitalisation301
  • insomnia276
  • intentional product use issue274
  • anxiety263
  • drug administration error241
  • condition aggravated234
  • drug dose omission224
  • dyskinesia224

Reports by year received

View as table
YearReports
20048
20054
20063
20076
20084
2009187
2010450
2011279
2012319
2013353
20141,453
20151,833
2016560
2017699
2018201
2019139
2020145
2021162
2022124
202397
2024119
202591
202691

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,832 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
drug administration errorSignal24122.720.14,949
dyskinesiaSignal22415.914.03,103
intentional product use issueSignal2749.08.01,943
somnolenceSignal4516.45.92,083
depressionSignal4766.05.52,003
hospitalisationSignal3015.65.01,148
deathSignal1,2224.13.92,951
drug dose omissionSignal2243.93.4482
off label useSignal1,1383.73.52,371
insomniaSignal2763.02.7365
fallSignal3182.72.5356
anxietySignal2632.72.4273
condition aggravatedSignal2342.21.9156
drug ineffective7081.51.4143
fatigue3611.31.231

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.